Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
Harvard Business School
McKesson
Mallinckrodt
Covington

Generated: July 18, 2019

DrugPatentWatch Database Preview

Desonide - Generic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

What are the generic sources for desonide and what is the scope of desonide patent protection?

Desonide is the generic ingredient in four branded drugs marketed by Almirall, Acp Nimble, Glenmark Pharms, Perrigo New York, Taro, Galderma Labs Lp, Leo Pharma As, Fougera Pharms, Taro Pharm, Teligent Pharma Inc, Encube Ethicals, Glenmark Pharms Ltd, and Hi Tech, and is included in twenty NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desonide has eighty-one patent family members in twenty-five countries.

There are thirty-one drug master file entries for desonide. Twenty suppliers are listed for this compound.

Pharmacology for desonide
Medical Subject Heading (MeSH) Categories for desonide
Synonyms for desonide
(11ss,16alpha)-11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0;{2,9}.0;{4,8}.0;{13,18}]icosa-14,17-dien-16-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone
11beta,21-dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione
16-alpha-Hydroxyprednisole-16,17-acetonide
16?,17-[1-Methylethylidenebis(oxy)]-11?,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-hydroxyprednisole-16,17-acetonide
16alpha-hydroxyprednisolone-16alpha,17-acetonide
16alpha,17-[1-Methylethylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione (Desonide)
16alpha,17alpha-isopropylidenedioxyprednisolone
638-94-8
638D948
AB01274712_02
AB01274712-01
AB2000229
Apolar
AS-13892
BCP04201
BRD-K21528677-001-03-6
C-22009
CAS-638-94-8
CC-26356
CCG-221279
CHEBI:204734
CHEMBL1201109
CS-2228
D 2083
D-2083
D03696
D2083
DB01260
desfluorotriamcinolone acetonide
Desilux
Desonate
Desonida
Desonida [INN-Spanish]
Desonide (USAN/INN)
Desonide [USAN:INN:BAN]
Desonidum
Desonidum [INN-Latin]
DesOwen
Desowen (TN)
DSSTox_CID_26756
DSSTox_GSID_46756
DSSTox_RID_81880
DTXSID7046756
EINECS 211-351-6
Flusemidon
GTPL7066
Hamiltoderm
HMS3715P20
HY-B0248
J280872D1O
K016
Locapred
Locapred;Topifug;Tridesilon
MolPort-003-987-087
NCGC00167983-01
NCGC00274065-01
Prednacinolone
Prednisolone-16,17-acetonide, 16-alpha-hydroxy-
Pregna-1,4-diene-3,20-dione, 11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-
Prenacid
Q-101382
Reticus
s1701
SC-17104
SCHEMBL3631
Sterax
Steroderm
TL8004516
Topifug
Tox21_112603
Tox21_112603_1
Tridesilon
Tridesonit
UNII-J280872D1O
Verdeso
Verdeso (TN)
WBGKWQHBNHJJPZ-LECWWXJVSA-N
ZINC4212851
Zotinar

US Patents and Regulatory Information for desonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro DESONIDE desonide OINTMENT;TOPICAL 074254-001 Aug 3, 1994 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Galderma Labs Lp DESOWEN desonide OINTMENT;TOPICAL 071425-001 Jun 15, 1988 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Galderma Labs Lp DESOWEN desonide CREAM;TOPICAL 019048-001 Dec 14, 1984 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Leo Pharma As DESONATE desonide GEL;TOPICAL 021844-001 Oct 20, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Teligent Pharma Inc DESONIDE desonide OINTMENT;TOPICAL 212002-001 Mar 12, 2019 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for desonide

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 474 Finland ➤ Try a Free Trial
1304992 122013000081 Germany ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992 PA2013025 Lithuania ➤ Try a Free Trial PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1304992 C300617 Netherlands ➤ Try a Free Trial PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
1304992 1390049-3 Sweden ➤ Try a Free Trial PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Fish and Richardson
Queensland Health
Boehringer Ingelheim
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.